Letermovir

Letermovir
Product Description

Letermovir (CAS-RN 917389-32-3) is an antiviral agent approved in 2017 by the US FDA to be used in prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). Designated an orphan drug by FDA for prevention of CMV viremia and disease in at-risk populations.

Read more Show less

Lebsa

  • Country/Region:
    Spain
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    25 - 49
Company types
Pharmaceutical company
Primary activities
API Producer
View company profile
Categories
more categories Show less

Lebsa

  • Country/Region:
    Spain
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    25 - 49
Company types
Pharmaceutical company
Primary activities
API Producer
View company profile

More Products from Lebsa (2)

  • Octenidine dihydrochloride

    Product Octenidine dihydrochloride

    Octenidine dihydrochloride (CAS 70775-75-6) is an antiseptic  manufactured in our unique European GMP manufacturing plant located in Barcelona, Spain. Octenidine dihydrochloride (CAS 70775-75-6)  is available with full regulatory support, inc...
  • Venetoclax

    Product Venetoclax

    We offer an integral secure solution as your startegic partner of Venetoclax. 
    Venetoclax (CAS 1257044-40-8) is a targeted therapy drug used to treat chronic lymphocytic leukaemia (CLL),  manufactured in our unique European GMP manufacturing plant located in Barcel...

Lebsa resources (1)